Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:

NCT ID: NCT04880330 Completed - Clinical trials for Tobacco Use Cessation

Interest of an Auriculotherapy Session in Smoking Cessation

StopAuric
Start date: November 16, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to show that auriculotherapy is effective in smoking cessation.

NCT ID: NCT04827420 Recruiting - Clinical trials for Tobacco Use Cessation

Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking. The specific aims of are to: UG3: Aim 1. Examine the burden of tobacco use and its influence on pulmonary health disparities (lung cancer, COPD, and asthma) in the patient population and the economically disadvantaged and racially segregated catchment areas of Mile Square Health Centers. Aim 2: Evaluate among MSHC patients and health care providers, knowledge, attitudes, barriers and facilitators related to smoking cessation, engagement with the tobacco quit line, linkage to the tobacco quit line via a patient health portal and receipt of patient navigation to facilitate access to the tobacco quit line. Aim 3: Evaluate the use of community engagement strategies to increase uptake of the UI Health Patient Portal among low-income patients receiving care at Mile Square Health Center. Aim 4: Test the acceptability, feasibility, and capacity of Mile Square Health to deliver Mi Quit CARE, an evidence-based and multi-level intervention to increase engagement with the quit line via the UI Health Portal. UH3: Aim 1: Determine the effectiveness Mi Quit CARE compared to standard of care in increasing patient engagement with the Illinois tobacco quitline and subsequent smoking cessation outcomes. Aim 2: Evaluate the scalability of Mi Quit CARE to multiple sites within the UI Health FQHC Mile Square clinic network and by translating the intervention to Spanish. Aim 3: Examine the cost effectiveness of Mi Quit CARE on smoking cessation outcomes compared to standard of care among a high risk FQHC population.

NCT ID: NCT04768114 Completed - Smoking Cessation Clinical Trials

Implementation of Genomics in Substance Use Disorder Treatment

Start date: March 19, 2021
Phase: N/A
Study type: Interventional

Cigarette smoking remains one of the leading causes of preventable death. Effective smoking cessation medications exist but use of these treatments is low, making it difficult for most to quit smoking. Behavioral interventions are needed to engage current smokers in the process of quitting smoking and promote the use of evidence-based cessation medications. At the same time, genetics influences one's smoking behaviors (e.g., how much they smoke, difficulty quitting) and risk of smoking-related diseases, yet these personalized factors have not been included in existing behavioral interventions. Incorporating these individualized factors into smoking cessation interventions may make them more personally engaging and thus motivating for treatment. This study will pilot test a risk communication tool that is personalized to one's genetics and will demonstrate the feasibility of a larger trial to test the effect of this personalized genetically-informed intervention on smoking cessation.

NCT ID: NCT04610931 Recruiting - Clinical trials for Tobacco Use Cessation

Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation

3DSmoke
Start date: September 2, 2021
Phase: N/A
Study type: Interventional

Tobacco is an addiction with serious consequences: somatic, psychiatric... The number of requests for treatment for tobacco addiction is gradually increasing from year to year, but conventional treatments have limited effectiveness. New tools such as virtual reality could be used in this treatment. We propose to create a virtual reality program based on the analysis of high-risk relapse situations. The investigator will then evaluate the effect of this cybertherapy on patients' relapse time and their desire to smoke.

NCT ID: NCT04606797 Completed - Clinical trials for Tobacco Use Cessation

Targeting Mailed Nicotine Patch Distribution Interventions to Rural Regions of Canada

Start date: November 23, 2020
Phase: Phase 4
Study type: Interventional

This study will examine the impact of mailed distribution of free Nicotine Replacement Therapy to smokers in rural regions. Telephone numbers will be randomly selected from across Canada in order to recruit adult smokers interested in completing a smoking survey and willing to be interviewed again in 6 months time. Study participants will be asked about their smoking history and a hypothetical question: would they be interested in receiving the nicotine patches if this were to be provided to them free of charge? Participants expressing interest will be randomly assigned to one of two groups. One group will be offered the opportunity to actually receive a program of 5 weeks of the nicotine patch for free right away and the other group will not be offered the free nicotine patches. The proportions of smokers in the two groups who quit smoking by the 6-month interview will be compared. Characteristics of the participants and the municipalities in which they live will be used to explain why the nicotine patch intervention has a larger impact in some rural regions compared to others This projects seeks to determine the impact of mailed NRT intervention on increasing quit rates in rural areas. In addition, it seeks to understand the social determinants of health driving the large effects expected based on previous findings.

NCT ID: NCT04594304 Recruiting - Tobacco Use Clinical Trials

Screening While You Wait 2: Alcohol and Tobacco Use

SWYW2
Start date: January 2, 2020
Phase: N/A
Study type: Interventional

This project aims to help patients improve their health through screening and treatment of risky alcohol and tobacco use. Previous studies show the best approach to reduce substance use includes routine screening, short discussions with a clinician, and tailored resources. Unfortunately, primary care providers (PCPs) do not often screen or provide evidence-based interventions. PCPs report lack of confidence, lack of awareness, and competing priorities as barriers to screening and providing evidence-based care. However, digital solutions can enable patient-initiated screening and overcome barriers in a manner that has the potential to be both efficient and effective. The proposed project will test the feasibility of digital patient-initiated screening at the WCH Family Practice (WCH FP) for alcohol and tobacco use, building on work from the first iteration of Screen While You Wait (SWYW). The research team will email patients a secure link to a survey with screening questions assessing substance use and important contextual factors. The results will be summarized in the patient's chart with an automatic notification to the PCP. If the survey reveals risky behaviours, both the PCP and patient will receive a package of tailored resources for further care delivered through a customized website.

NCT ID: NCT04540081 Completed - Obesity Clinical Trials

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

CLOVER
Start date: October 5, 2020
Phase: N/A
Study type: Interventional

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

NCT ID: NCT04534231 Completed - Clinical trials for Tobacco Use Cessation

Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates

Start date: October 19, 2020
Phase:
Study type: Observational

One municipality with high smoking rates will be selected. A coupon for free-of-charge nicotine patches will be sent to each household. Reductions in the number of people smoking in the chosen municipality from before to after the NRT distribution will be estimated

NCT ID: NCT04490057 Active, not recruiting - Clinical trials for Tobacco Use Cessation

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

SMARTTT
Start date: July 27, 2020
Phase: Phase 4
Study type: Interventional

Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.

NCT ID: NCT04427839 Recruiting - Clinical trials for Tobacco Use Cessation

Expanding Population-level Interventions to Help More Low-income Smokers Quit

SFH
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

In a Hybrid Type 2 randomized trial, 1,980 low-income smokers from nine states with high smoking prevalence will be recruited from 2-1-1 helplines to receive either current standard practice (Quitline) or expanded services (Quitline + Smoke Free Homes) to increase tobacco cessation.